Cardiovascular Consequences of Autoimmune Rheumatic Diseases.

doi:10.2174/1570161118666200127142936

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Cardiovascular Consequences of Autoimmune Rheumatic Diseases.

Current vascular pharmacology - 1 Jan 2020

Atzeni Fabiola, Nucera Valeria, Gerratana Elisabetta, Fiorenza Alessia, Gianturco Luigi, Corda Marco, Sarzi-Puttini Piercarlo

Abstract excerpt

The increased risk of cardiovascular disease (CVD) among patients with autoimmune rheumatic diseases such as rheumatoid arthritis, spondyloarthritis and systemic lupus erythematosus has been extensively documented. Sub-clinical atherosclerosis can be assessed using various non-invasive imaging techniques. However, the mechanisms underlying the higher risk of atherosclerotic CVD in patients with autoimmune...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoimmune Diseases
Share to Cardiovascular Diseases
Share to Comorbidity
Share to Heart Disease Risk Factors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Inflammation

Share to Life Style

Share to Protective Factors

Share to Rheumatic Diseases

Source

Open in PubMed

Identifiers

PMID: 31985379
DOI: 10.2174/1570161118666200127142936

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.